Phyto Chem (India) (524808) 주식 개요Phyto Chem (India) Limited는 인도에서 농업 부문을 위한 농약을 제조 및 판매하는 회사입니다. 자세히 보기524808 펀더멘털 분석스노우플레이크 점수가치 평가2/6미래 성장0/6과거 실적0/6재무 건전성4/6배당0/6강점공정 가치 추정치보다 낮은 0.4% 에서 거래위험 분석수익이 USD$1m 미만입니다(₹91M)의미 있는 시가총액이 없습니다(₹85M)지난 5년간 매년 수익이 44% 감소했습니다.지난 3개월 동안 주가 변동성이 Indian 시장과 비교해 높았습니다.모든 위험 점검 보기524808 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW477,415 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA477,415 investors already sharing narrativesYour Fair Value₹Current Price₹19.70239.7% 고평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-30m718m2016201920222025202620282031Revenue ₹30.9mEarnings ₹2.9mAdvancedSet Fair ValueView all narrativesPhyto Chem (India) Limited 경쟁사Shiva Global Agro IndustriesSymbol: BSE:530433Market cap: ₹383.7mAimco PesticidesSymbol: BSE:524288Market cap: ₹447.0mPhosphateSymbol: BSE:542123Market cap: ₹505.0mAgro Phos (India)Symbol: NSEI:AGROPHOSMarket cap: ₹554.1m가격 이력 및 성과Phyto Chem (India) 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가₹19.7052주 최고가₹34.9952주 최저가₹18.53베타0.621개월 변동-17.12%3개월 변동-17.57%1년 변동-28.34%3년 변동-51.19%5년 변동-3.90%IPO 이후 변동131.76%최근 뉴스 및 업데이트New Risk • Aug 15New major risk - Revenue sizeThe company makes less than US$1m in revenue. Total revenue: ₹91m (US$948k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 44% per year over the past 5 years. Revenue is less than US$1m (₹91m revenue, or US$948k). Market cap is less than US$10m (₹84.7m market cap, or US$886.0k). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).공고 • Aug 06Phyto Chem (India) Limited to Report Q1, 2027 Results on Aug 13, 2026Phyto Chem (India) Limited announced that they will report Q1, 2027 results on Aug 13, 2026Reported Earnings • May 31Full year 2026 earnings released: ₹4.19 loss per share (vs ₹2.31 loss in FY 2025)Full year 2026 results: ₹4.19 loss per share (further deteriorated from ₹2.31 loss in FY 2025). Revenue: ₹109.0m (down 30% from FY 2025). Net loss: ₹18.0m (loss widened 82% from FY 2025). Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 8% per year.공고 • May 22Phyto Chem (India) Limited to Report Q4, 2026 Results on May 29, 2026Phyto Chem (India) Limited announced that they will report Q4, 2026 results on May 29, 2026Buy Or Sell Opportunity • Apr 29Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to ₹24.00. The fair value is estimated to be ₹30.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Meanwhile, the company became loss making.New Risk • Mar 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.2% average weekly change). Earnings have declined by 53% per year over the past 5 years. Market cap is less than US$10m (₹100.4m market cap, or US$1.07m). Minor Risk Revenue is less than US$5m (₹118m revenue, or US$1.3m).더 많은 업데이트 보기Recent updatesNew Risk • Aug 15New major risk - Revenue sizeThe company makes less than US$1m in revenue. Total revenue: ₹91m (US$948k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 44% per year over the past 5 years. Revenue is less than US$1m (₹91m revenue, or US$948k). Market cap is less than US$10m (₹84.7m market cap, or US$886.0k). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).공고 • Aug 06Phyto Chem (India) Limited to Report Q1, 2027 Results on Aug 13, 2026Phyto Chem (India) Limited announced that they will report Q1, 2027 results on Aug 13, 2026Reported Earnings • May 31Full year 2026 earnings released: ₹4.19 loss per share (vs ₹2.31 loss in FY 2025)Full year 2026 results: ₹4.19 loss per share (further deteriorated from ₹2.31 loss in FY 2025). Revenue: ₹109.0m (down 30% from FY 2025). Net loss: ₹18.0m (loss widened 82% from FY 2025). Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 8% per year.공고 • May 22Phyto Chem (India) Limited to Report Q4, 2026 Results on May 29, 2026Phyto Chem (India) Limited announced that they will report Q4, 2026 results on May 29, 2026Buy Or Sell Opportunity • Apr 29Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to ₹24.00. The fair value is estimated to be ₹30.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Meanwhile, the company became loss making.New Risk • Mar 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.2% average weekly change). Earnings have declined by 53% per year over the past 5 years. Market cap is less than US$10m (₹100.4m market cap, or US$1.07m). Minor Risk Revenue is less than US$5m (₹118m revenue, or US$1.3m).Buy Or Sell Opportunity • Mar 19Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to ₹24.44. The fair value is estimated to be ₹30.67, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Mar 04Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 20% to ₹22.94. The fair value is estimated to be ₹29.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • Feb 18Third quarter 2026 earnings released: ₹1.13 loss per share (vs ₹3.54 profit in 3Q 2025)Third quarter 2026 results: ₹1.13 loss per share (down from ₹3.54 profit in 3Q 2025). Revenue: ₹32.8m (down 41% from 3Q 2025). Net loss: ₹4.85m (down 132% from profit in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.공고 • Feb 06Phyto Chem (India) Limited to Report Q3, 2026 Results on Feb 14, 2026Phyto Chem (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 14, 2026New Risk • Dec 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Earnings have declined by 54% per year over the past 5 years. Market cap is less than US$10m (₹134.5m market cap, or US$1.50m). Minor Risk Revenue is less than US$5m (₹125m revenue, or US$1.4m).공고 • Nov 08Phyto Chem (India) Limited to Report Q2, 2026 Results on Nov 14, 2025Phyto Chem (India) Limited announced that they will report Q2, 2026 results on Nov 14, 2025공고 • Sep 05Phyto Chem (India) Limited, Annual General Meeting, Sep 29, 2025Phyto Chem (India) Limited, Annual General Meeting, Sep 29, 2025, at 12:15 Indian Standard Time. Location: survey no.628, temple street, bonthapally - 502313, gummadidala mandal, sangareddy dist, telangana, India공고 • Aug 02Phyto Chem (India) Limited to Report Q1, 2026 Results on Aug 11, 2025Phyto Chem (India) Limited announced that they will report Q1, 2026 results on Aug 11, 2025New Risk • Jul 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.4x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.4x net interest cover). Share price has been highly volatile over the past 3 months (8.3% average weekly change). Earnings have declined by 68% per year over the past 5 years. Market cap is less than US$10m (₹122.3m market cap, or US$1.41m). Minor Risk Revenue is less than US$5m (₹141m revenue, or US$1.6m).New Risk • Jul 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Earnings have declined by 70% per year over the past 5 years. Market cap is less than US$10m (₹125.5m market cap, or US$1.46m). Minor Risk Revenue is less than US$5m (₹141m revenue, or US$1.6m).Reported Earnings • May 28Full year 2025 earnings released: ₹2.31 loss per share (vs ₹7.75 loss in FY 2024)Full year 2025 results: ₹2.31 loss per share (improved from ₹7.75 loss in FY 2024). Revenue: ₹165.5m (down 1.5% from FY 2024). Net loss: ₹9.92m (loss narrowed 70% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 98 percentage points per year, which is a significant difference in performance.공고 • Apr 01Phyto Chem (India) Limited Appoints Venkata Satish Babu Turlapati as Company Secretary and Compliance Officer, Effective March 31, 2025Phyto Chem (India) Limited at its Boards of Directors meeting held on March 31, 2025, approved the appointment of Mr. Venkata Satish Babu Turlapati Company Secretary and Compliance Officer of the Company, effective March 31, 2025. Mr. Venkata Satish Babu Turlapati is a Fellow Member of the Institute of Company Secretaries of India (ICSI). He holds Degrees in Law and Commerce. With over three decades of experience, he has worked across listed and unlisted entities, specializing in corporate compliance, secretarial functions, and regulatory affairs under the Companies Act and SEBI regulations. He has a diverse professional background with expertise in the field of Secretarial and Legal matters. Mr. Venkata Satish Babu Turlapati is not related to any Director or KMP of the Company.Reported Earnings • Nov 16Second quarter 2025 earnings released: EPS: ₹0.26 (vs ₹0.37 loss in 2Q 2024)Second quarter 2025 results: EPS: ₹0.26 (up from ₹0.37 loss in 2Q 2024). Revenue: ₹43.8m (down 39% from 2Q 2024). Net income: ₹1.11m (up ₹2.72m from 2Q 2024). Profit margin: 2.5% (up from net loss in 2Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 126 percentage points per year, which is a significant difference in performance.New Risk • Sep 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Earnings have declined by 72% per year over the past 5 years. Market cap is less than US$10m (₹137.6m market cap, or US$1.65m). Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Revenue is less than US$5m (₹188m revenue, or US$2.2m).공고 • Sep 05Phyto Chem (India) Limited, Annual General Meeting, Sep 27, 2024Phyto Chem (India) Limited, Annual General Meeting, Sep 27, 2024, at 11:45 Indian Standard Time. Location: survey no. 628, temple street, gummadidala mandal, sangareddy district, bonthapally - 502313, telangana., bonthapally India공고 • Sep 03+ 2 more updatesPhyto Chem (India) Limited to Report Q3, 2025 Results on Feb 14, 2025Phyto Chem (India) Limited announced that they will report Q3, 2025 results on Feb 14, 2025Reported Earnings • Aug 15First quarter 2025 earnings released: ₹3.41 loss per share (vs ₹4.08 loss in 1Q 2024)First quarter 2025 results: ₹3.41 loss per share (improved from ₹4.08 loss in 1Q 2024). Revenue: ₹46.2m (up ₹39.7m from 1Q 2024). Net loss: ₹14.7m (loss narrowed 16% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 129 percentage points per year, which is a significant difference in performance.공고 • Aug 04Phyto Chem (India) Limited to Report Q1, 2025 Results on Aug 12, 2024Phyto Chem (India) Limited announced that they will report Q1, 2025 results on Aug 12, 2024Reported Earnings • Jun 04Full year 2024 earnings released: ₹7.75 loss per share (vs ₹0.52 profit in FY 2023)Full year 2024 results: ₹7.75 loss per share (down from ₹0.52 profit in FY 2023). Revenue: ₹171.3m (down 36% from FY 2023). Net loss: ₹33.3m (down ₹35.5m from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 128 percentage points per year, which is a significant difference in performance.공고 • May 22Phyto Chem (India) Limited to Report Q4, 2024 Results on May 29, 2024Phyto Chem (India) Limited announced that they will report Q4, 2024 results on May 29, 2024Reported Earnings • Feb 13Third quarter 2024 earnings released: EPS: ₹0.68 (vs ₹0.72 loss in 3Q 2023)Third quarter 2024 results: EPS: ₹0.68 (up from ₹0.72 loss in 3Q 2023). Revenue: ₹65.8m (down 17% from 3Q 2023). Net income: ₹2.93m (up ₹6.02m from 3Q 2023). Profit margin: 4.5% (up from net loss in 3Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 120 percentage points per year, which is a significant difference in performance.공고 • Feb 03Phyto Chem (India) Limited to Report Q3, 2024 Results on Feb 12, 2024Phyto Chem (India) Limited announced that they will report Q3, 2024 results on Feb 12, 2024Reported Earnings • Nov 03Second quarter 2024 earnings released: ₹0.37 loss per share (vs ₹4.60 profit in 2Q 2023)Second quarter 2024 results: ₹0.37 loss per share (down from ₹4.60 profit in 2Q 2023). Revenue: ₹72.1m (down 42% from 2Q 2023). Net loss: ₹1.60m (down 108% from profit in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 110 percentage points per year, which is a significant difference in performance.공고 • Aug 10Phyto Chem (India) Limited Approves Appointment of N. Nagendra Naidu as Non-Executive Independent DirectorPhyto Chem (India) Limited at the Annual General meeting held on August 7, 2023, approved appointment of Mr. N. Nagendra Naidu (DIN: 10180163) as a Non-Executive Independent Director of the Company.New Risk • Aug 08New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Earnings have declined by 18% per year over the past 5 years. Market cap is less than US$10m (₹165.9m market cap, or US$2.00m). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Revenue is less than US$5m (₹262m revenue, or US$3.2m).공고 • Jul 29Phyto Chem (India) Limited to Report Q1, 2024 Results on Aug 07, 2023Phyto Chem (India) Limited announced that they will report Q1, 2024 results on Aug 07, 2023Reported Earnings • Jul 15Full year 2023 earnings released: EPS: ₹0.52 (vs ₹0.54 in FY 2022)Full year 2023 results: EPS: ₹0.52 (down from ₹0.54 in FY 2022). Revenue: ₹267.6m (up 16% from FY 2022). Net income: ₹2.22m (down 3.3% from FY 2022). Profit margin: 0.8% (down from 1.0% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.공고 • Jul 14Phyto Chem (India) Limited, Annual General Meeting, Aug 07, 2023Phyto Chem (India) Limited, Annual General Meeting, Aug 07, 2023, at 11:30 Indian Standard Time. Location: Survey No.628, Temple Street, Bonthapally - 502 313 Gummadidala Mandal, Sangareddy District, Telangana State Sangareddy India Agenda: To consider and approve the Audited Financial Statements of the Company as at 31 March 2023, along with the Reports of the Board of Directors and Auditors thereon; to consider and approve the appointment of a Director in place of Mr. Anjaneyulu Prathipati who retires by rotation and being eligible, offers himself for reappointment; and to consider other matters.Valuation Update With 7 Day Price Move • Jun 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹38.44, the stock trades at a trailing P/E ratio of 74.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 33% over the past three years.Reported Earnings • May 30Full year 2023 earnings released: EPS: ₹0.52 (vs ₹0.54 in FY 2022)Full year 2023 results: EPS: ₹0.52 (down from ₹0.54 in FY 2022). Revenue: ₹269.2m (up 16% from FY 2022). Net income: ₹2.22m (down 3.3% from FY 2022). Profit margin: 0.8% (down from 1.0% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings.공고 • May 06Phyto Chem (India) Limited Announces Resignation of K.Ravindra Babu as an Independent Director, Effective from May 12, 2023Phyto Chem (India) Limited announced that Mr. K.Ravindra Babu has resigned from the position of the independent director of the company with effect from May 12, 2023.Valuation Update With 7 Day Price Move • Mar 24Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₹27.14, the stock trades at a trailing P/E ratio of 78.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 51% over the past three years.Reported Earnings • Feb 16Third quarter 2023 earnings released: ₹0.72 loss per share (vs ₹1.21 profit in 3Q 2022)Third quarter 2023 results: ₹0.72 loss per share (down from ₹1.21 profit in 3Q 2022). Revenue: ₹79.4m (up 4.1% from 3Q 2022). Net loss: ₹3.09m (down 160% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 36% per year, which means it is well ahead of earnings.공고 • Feb 07Phyto Chem (India) Limited to Report Q3, 2023 Results on Feb 14, 2023Phyto Chem (India) Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 14, 2023Valuation Update With 7 Day Price Move • Feb 03Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹61.95, the stock trades at a trailing P/E ratio of 27.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 169% over the past three years.Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹67.50, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 170% over the past three years.Valuation Update With 7 Day Price Move • Jan 02Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹50.15, the stock trades at a trailing P/E ratio of 22.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 116% over the past three years.Valuation Update With 7 Day Price Move • Dec 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹35.85, the stock trades at a trailing P/E ratio of 15.8x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 78% over the past three years.Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹34.40, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 47% over the past three years.공고 • Oct 23Phyto Chem (India) Limited to Report Q2, 2023 Results on Oct 31, 2022Phyto Chem (India) Limited announced that they will report Q2, 2023 results at 2:30 PM, Indian Standard Time on Oct 31, 2022Valuation Update With 7 Day Price Move • Sep 09Investor sentiment improved over the past weekAfter last week's 25% share price gain to ₹20.60, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.공고 • Sep 06Phyto Chem (India) Limited, Annual General Meeting, Sep 28, 2022Phyto Chem (India) Limited, Annual General Meeting, Sep 28, 2022, at 11:45 Indian Standard Time. Location: Registered Office at Survey No. 628, Temple Street, Bonthapally Gummadidala Mandal Sangareddy India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company as at 31% March 2022, along with the Reports of the Board of Directors and Auditors thereon; to consider directorate reelections; and to consider other matters.Reported Earnings • Aug 10First quarter 2023 earnings released: ₹3.65 loss per share (vs ₹3.38 loss in 1Q 2022)First quarter 2023 results: ₹3.65 loss per share (down from ₹3.38 loss in 1Q 2022). Revenue: ₹14.1m (down 16% from 1Q 2022). Net loss: ₹15.7m (loss widened 8.0% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.Reported Earnings • Feb 15Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.21 (up from ₹0.94 in 3Q 2021). Revenue: ₹76.7m (up 31% from 3Q 2021). Net income: ₹5.18m (up 29% from 3Q 2021). Profit margin: 6.8% (down from 6.9% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.Reported Earnings • Jul 04Full year 2021 earnings released: EPS ₹1.15 (vs ₹1.04 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹452.9m (up 2.4% from FY 2020). Net income: ₹4.93m (up 11% from FY 2020). Profit margin: 1.1% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 23% per year, which means it is performing significantly worse than earnings.Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹26.80, the stock trades at a trailing P/E ratio of 21.5x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.Is New 90 Day High Low • Feb 22New 90-day low: ₹20.60The company is down 8.0% from its price of ₹22.35 on 24 November 2020. The Indian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.Reported Earnings • Feb 13Third quarter 2021 earnings released: EPS ₹0.94 (vs ₹0.73 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹61.0m (down 65% from 3Q 2020). Net income: ₹4.03m (up 28% from 3Q 2020). Profit margin: 6.6% (up from 1.8% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 31% per year whereas the company’s share price has fallen by 26% per year.공고 • Feb 05Phyto Chem (India) Limited to Report Q3, 2021 Results on Feb 12, 2021Phyto Chem (India) Limited announced that they will report Q3, 2021 results on Feb 12, 2021Is New 90 Day High Low • Jan 04New 90-day high: ₹27.85The company is up 7.0% from its price of ₹26.15 on 06 October 2020. The Indian market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹25.65, the stock is trading at a trailing P/E ratio of 24.6x, up from the previous P/E ratio of 20.9x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 66%.공고 • Dec 06Phyto Chem (India) Limited, Annual General Meeting, Dec 28, 2020Phyto Chem (India) Limited, Annual General Meeting, Dec 28, 2020, at 11:45 Indian Standard Time. Location: Survey No.628, Tem ple Street Bonthapally - 502 313, Gummadidala Mandal Sangareddy Andhra Pradesh India Agenda: To consider and adopt the Audited Balance Sheet as at March 31, 2020, Profit and Loss Account and Cash Flow Statement for the year ended on that date along with the Reports of the Board of Directors and Auditors thereon; to consider the re-appointment of Mr. Anjaneyulu Prathipati as Director; to consider the re-appointment of Dr. G.S.R.Anjaneyulu as a Non-Executive Independent Director of the company; to consider the appointment of Mr. Ravindra Babu Kakarla as a Non-Executive Independent Director of the company; to consider the appointment of Mr. Yugandhar Sampath Kumar Sakhamuri as a Non-Executive Independent Director of the Company; to consider the appointment of Mrs. Vijitha Gorrepati as a Woman Non-Executive Independent Director of the Company; and to consider the Continuation of Directorship of Dr. Venkateswarlu Yadlapalli as a Non- Executive Non-Independent Director.Reported Earnings • Nov 16Second quarter 2021 earnings released: EPS ₹2.91The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹177.1m (down 15% from 2Q 2020). Net income: ₹12.5m (down 19% from 2Q 2020). Profit margin: 7.1% (down from 7.4% in 2Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.공고 • Nov 13Phyto Chem (India) Limited Announces Cessation of Independent DirectorsPhyto Chem (India) Limited announced that Mr. N. Sudhakar, Mr. T. A. Choudary and Mrs. S. Kavitha Rani as the cessation of independent directors effect from November 12, 2020.Valuation Update With 7 Day Price Move • Oct 28Market bids up stock over the past weekAfter last week's 17% share price gain to ₹23.95, the stock is trading at a trailing P/E ratio of 13.8x, up from the previous P/E ratio of 11.8x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 62%.Valuation Update With 7 Day Price Move • Oct 14Market pulls back on stock over the past weekAfter last week's 15% share price decline to ₹22.05, the stock is trading at a trailing P/E ratio of 12.7x, down from the previous P/E ratio of 15x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 65%.Is New 90 Day High Low • Sep 18New 90-day low: ₹21.85The company is down 22% from its price of ₹28.00 on 19 June 2020. The Indian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period.공고 • Sep 08Phyto Chem (India) Limited to Report Q1, 2021 Results on Sep 14, 2020Phyto Chem (India) Limited announced that they will report Q1, 2021 results on Sep 14, 2020주주 수익률524808IN ChemicalsIN 시장7D-0.8%0.6%-0.4%1Y-28.3%1.9%4.6%전체 주주 수익률 보기수익률 대 산업: 524808은 지난 1년 동안 1.9%의 수익을 기록한 Indian Chemicals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: 524808은 지난 1년 동안 4.6%를 기록한 Indian 시장보다 저조한 성과를 냈습니다.주가 변동성Is 524808's price volatile compared to industry and market?524808 volatility524808 Average Weekly Movement8.1%Chemicals Industry Average Movement5.9%Market Average Movement5.9%10% most volatile stocks in IN Market9.0%10% least volatile stocks in IN Market3.6%안정적인 주가: 524808의 주가는 지난 3개월 동안 Indian 시장보다 변동성이 컸습니다.시간에 따른 변동성: 524808의 주간 변동성(8%)은 지난 1년 동안 안정적이었지만 Indian 종목 중 상위 75%보다 높습니다.회사 소개설립직원 수CEO웹사이트198936Yarlagadda Nayudammawww.phytochemindia.com피토 켐(인도)은 인도에서 농업 부문을 위한 살충제를 제조 및 판매하는 회사입니다. 이 회사는 농약 제형 및 부동산 활동 부문을 통해 운영됩니다. 이 회사의 제품에는 액상 및 SC, 제초제, 습식 및 분말, 과립 제제가 포함됩니다.더 보기Phyto Chem (India) Limited 기초 지표 요약Phyto Chem (India)의 순이익과 매출은 시가총액과 어떻게 비교됩니까?524808 기초 통계시가총액₹84.71m순이익 (TTM)-₹22.23m매출 (TTM)₹90.64m0.9x주가매출비율(P/S)-3.8x주가수익비율(P/E)524808는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표524808 손익계산서 (TTM)매출₹90.64m매출원가₹73.71m총이익₹16.93m기타 비용₹39.16m순이익-₹22.23m최근 보고된 실적Jun 30, 2026다음 실적 발표일해당 없음주당순이익(EPS)-5.17총이익률18.68%순이익률-24.52%부채/자본 비율448.5%524808의 장기 실적은 어땠습니까?과거 실적 및 비교 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/17 10:24종가2026/08/14 00:00수익2026/06/30연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Phyto Chem (India) Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
New Risk • Aug 15New major risk - Revenue sizeThe company makes less than US$1m in revenue. Total revenue: ₹91m (US$948k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 44% per year over the past 5 years. Revenue is less than US$1m (₹91m revenue, or US$948k). Market cap is less than US$10m (₹84.7m market cap, or US$886.0k). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).
공고 • Aug 06Phyto Chem (India) Limited to Report Q1, 2027 Results on Aug 13, 2026Phyto Chem (India) Limited announced that they will report Q1, 2027 results on Aug 13, 2026
Reported Earnings • May 31Full year 2026 earnings released: ₹4.19 loss per share (vs ₹2.31 loss in FY 2025)Full year 2026 results: ₹4.19 loss per share (further deteriorated from ₹2.31 loss in FY 2025). Revenue: ₹109.0m (down 30% from FY 2025). Net loss: ₹18.0m (loss widened 82% from FY 2025). Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 8% per year.
공고 • May 22Phyto Chem (India) Limited to Report Q4, 2026 Results on May 29, 2026Phyto Chem (India) Limited announced that they will report Q4, 2026 results on May 29, 2026
Buy Or Sell Opportunity • Apr 29Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to ₹24.00. The fair value is estimated to be ₹30.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Mar 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.2% average weekly change). Earnings have declined by 53% per year over the past 5 years. Market cap is less than US$10m (₹100.4m market cap, or US$1.07m). Minor Risk Revenue is less than US$5m (₹118m revenue, or US$1.3m).
New Risk • Aug 15New major risk - Revenue sizeThe company makes less than US$1m in revenue. Total revenue: ₹91m (US$948k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 44% per year over the past 5 years. Revenue is less than US$1m (₹91m revenue, or US$948k). Market cap is less than US$10m (₹84.7m market cap, or US$886.0k). Minor Risk Share price has been volatile over the past 3 months (8.1% average weekly change).
공고 • Aug 06Phyto Chem (India) Limited to Report Q1, 2027 Results on Aug 13, 2026Phyto Chem (India) Limited announced that they will report Q1, 2027 results on Aug 13, 2026
Reported Earnings • May 31Full year 2026 earnings released: ₹4.19 loss per share (vs ₹2.31 loss in FY 2025)Full year 2026 results: ₹4.19 loss per share (further deteriorated from ₹2.31 loss in FY 2025). Revenue: ₹109.0m (down 30% from FY 2025). Net loss: ₹18.0m (loss widened 82% from FY 2025). Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 8% per year.
공고 • May 22Phyto Chem (India) Limited to Report Q4, 2026 Results on May 29, 2026Phyto Chem (India) Limited announced that they will report Q4, 2026 results on May 29, 2026
Buy Or Sell Opportunity • Apr 29Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to ₹24.00. The fair value is estimated to be ₹30.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Mar 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.2% average weekly change). Earnings have declined by 53% per year over the past 5 years. Market cap is less than US$10m (₹100.4m market cap, or US$1.07m). Minor Risk Revenue is less than US$5m (₹118m revenue, or US$1.3m).
Buy Or Sell Opportunity • Mar 19Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to ₹24.44. The fair value is estimated to be ₹30.67, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Mar 04Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 20% to ₹22.94. The fair value is estimated to be ₹29.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • Feb 18Third quarter 2026 earnings released: ₹1.13 loss per share (vs ₹3.54 profit in 3Q 2025)Third quarter 2026 results: ₹1.13 loss per share (down from ₹3.54 profit in 3Q 2025). Revenue: ₹32.8m (down 41% from 3Q 2025). Net loss: ₹4.85m (down 132% from profit in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 14% per year, which means it has not declined as severely as earnings.
공고 • Feb 06Phyto Chem (India) Limited to Report Q3, 2026 Results on Feb 14, 2026Phyto Chem (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 14, 2026
New Risk • Dec 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Earnings have declined by 54% per year over the past 5 years. Market cap is less than US$10m (₹134.5m market cap, or US$1.50m). Minor Risk Revenue is less than US$5m (₹125m revenue, or US$1.4m).
공고 • Nov 08Phyto Chem (India) Limited to Report Q2, 2026 Results on Nov 14, 2025Phyto Chem (India) Limited announced that they will report Q2, 2026 results on Nov 14, 2025
공고 • Sep 05Phyto Chem (India) Limited, Annual General Meeting, Sep 29, 2025Phyto Chem (India) Limited, Annual General Meeting, Sep 29, 2025, at 12:15 Indian Standard Time. Location: survey no.628, temple street, bonthapally - 502313, gummadidala mandal, sangareddy dist, telangana, India
공고 • Aug 02Phyto Chem (India) Limited to Report Q1, 2026 Results on Aug 11, 2025Phyto Chem (India) Limited announced that they will report Q1, 2026 results on Aug 11, 2025
New Risk • Jul 26New major risk - Financial positionThe company's interest payments are not well covered by earnings. Net interest cover: 0.4x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.4x net interest cover). Share price has been highly volatile over the past 3 months (8.3% average weekly change). Earnings have declined by 68% per year over the past 5 years. Market cap is less than US$10m (₹122.3m market cap, or US$1.41m). Minor Risk Revenue is less than US$5m (₹141m revenue, or US$1.6m).
New Risk • Jul 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.5% average weekly change). Earnings have declined by 70% per year over the past 5 years. Market cap is less than US$10m (₹125.5m market cap, or US$1.46m). Minor Risk Revenue is less than US$5m (₹141m revenue, or US$1.6m).
Reported Earnings • May 28Full year 2025 earnings released: ₹2.31 loss per share (vs ₹7.75 loss in FY 2024)Full year 2025 results: ₹2.31 loss per share (improved from ₹7.75 loss in FY 2024). Revenue: ₹165.5m (down 1.5% from FY 2024). Net loss: ₹9.92m (loss narrowed 70% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 98 percentage points per year, which is a significant difference in performance.
공고 • Apr 01Phyto Chem (India) Limited Appoints Venkata Satish Babu Turlapati as Company Secretary and Compliance Officer, Effective March 31, 2025Phyto Chem (India) Limited at its Boards of Directors meeting held on March 31, 2025, approved the appointment of Mr. Venkata Satish Babu Turlapati Company Secretary and Compliance Officer of the Company, effective March 31, 2025. Mr. Venkata Satish Babu Turlapati is a Fellow Member of the Institute of Company Secretaries of India (ICSI). He holds Degrees in Law and Commerce. With over three decades of experience, he has worked across listed and unlisted entities, specializing in corporate compliance, secretarial functions, and regulatory affairs under the Companies Act and SEBI regulations. He has a diverse professional background with expertise in the field of Secretarial and Legal matters. Mr. Venkata Satish Babu Turlapati is not related to any Director or KMP of the Company.
Reported Earnings • Nov 16Second quarter 2025 earnings released: EPS: ₹0.26 (vs ₹0.37 loss in 2Q 2024)Second quarter 2025 results: EPS: ₹0.26 (up from ₹0.37 loss in 2Q 2024). Revenue: ₹43.8m (down 39% from 2Q 2024). Net income: ₹1.11m (up ₹2.72m from 2Q 2024). Profit margin: 2.5% (up from net loss in 2Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 126 percentage points per year, which is a significant difference in performance.
New Risk • Sep 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (19% operating cash flow to total debt). Earnings have declined by 72% per year over the past 5 years. Market cap is less than US$10m (₹137.6m market cap, or US$1.65m). Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Revenue is less than US$5m (₹188m revenue, or US$2.2m).
공고 • Sep 05Phyto Chem (India) Limited, Annual General Meeting, Sep 27, 2024Phyto Chem (India) Limited, Annual General Meeting, Sep 27, 2024, at 11:45 Indian Standard Time. Location: survey no. 628, temple street, gummadidala mandal, sangareddy district, bonthapally - 502313, telangana., bonthapally India
공고 • Sep 03+ 2 more updatesPhyto Chem (India) Limited to Report Q3, 2025 Results on Feb 14, 2025Phyto Chem (India) Limited announced that they will report Q3, 2025 results on Feb 14, 2025
Reported Earnings • Aug 15First quarter 2025 earnings released: ₹3.41 loss per share (vs ₹4.08 loss in 1Q 2024)First quarter 2025 results: ₹3.41 loss per share (improved from ₹4.08 loss in 1Q 2024). Revenue: ₹46.2m (up ₹39.7m from 1Q 2024). Net loss: ₹14.7m (loss narrowed 16% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 129 percentage points per year, which is a significant difference in performance.
공고 • Aug 04Phyto Chem (India) Limited to Report Q1, 2025 Results on Aug 12, 2024Phyto Chem (India) Limited announced that they will report Q1, 2025 results on Aug 12, 2024
Reported Earnings • Jun 04Full year 2024 earnings released: ₹7.75 loss per share (vs ₹0.52 profit in FY 2023)Full year 2024 results: ₹7.75 loss per share (down from ₹0.52 profit in FY 2023). Revenue: ₹171.3m (down 36% from FY 2023). Net loss: ₹33.3m (down ₹35.5m from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 128 percentage points per year, which is a significant difference in performance.
공고 • May 22Phyto Chem (India) Limited to Report Q4, 2024 Results on May 29, 2024Phyto Chem (India) Limited announced that they will report Q4, 2024 results on May 29, 2024
Reported Earnings • Feb 13Third quarter 2024 earnings released: EPS: ₹0.68 (vs ₹0.72 loss in 3Q 2023)Third quarter 2024 results: EPS: ₹0.68 (up from ₹0.72 loss in 3Q 2023). Revenue: ₹65.8m (down 17% from 3Q 2023). Net income: ₹2.93m (up ₹6.02m from 3Q 2023). Profit margin: 4.5% (up from net loss in 3Q 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 120 percentage points per year, which is a significant difference in performance.
공고 • Feb 03Phyto Chem (India) Limited to Report Q3, 2024 Results on Feb 12, 2024Phyto Chem (India) Limited announced that they will report Q3, 2024 results on Feb 12, 2024
Reported Earnings • Nov 03Second quarter 2024 earnings released: ₹0.37 loss per share (vs ₹4.60 profit in 2Q 2023)Second quarter 2024 results: ₹0.37 loss per share (down from ₹4.60 profit in 2Q 2023). Revenue: ₹72.1m (down 42% from 2Q 2023). Net loss: ₹1.60m (down 108% from profit in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 110 percentage points per year, which is a significant difference in performance.
공고 • Aug 10Phyto Chem (India) Limited Approves Appointment of N. Nagendra Naidu as Non-Executive Independent DirectorPhyto Chem (India) Limited at the Annual General meeting held on August 7, 2023, approved appointment of Mr. N. Nagendra Naidu (DIN: 10180163) as a Non-Executive Independent Director of the Company.
New Risk • Aug 08New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.0x net interest cover). Earnings have declined by 18% per year over the past 5 years. Market cap is less than US$10m (₹165.9m market cap, or US$2.00m). Minor Risks Share price has been volatile over the past 3 months (7.8% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.1% net profit margin). Revenue is less than US$5m (₹262m revenue, or US$3.2m).
공고 • Jul 29Phyto Chem (India) Limited to Report Q1, 2024 Results on Aug 07, 2023Phyto Chem (India) Limited announced that they will report Q1, 2024 results on Aug 07, 2023
Reported Earnings • Jul 15Full year 2023 earnings released: EPS: ₹0.52 (vs ₹0.54 in FY 2022)Full year 2023 results: EPS: ₹0.52 (down from ₹0.54 in FY 2022). Revenue: ₹267.6m (up 16% from FY 2022). Net income: ₹2.22m (down 3.3% from FY 2022). Profit margin: 0.8% (down from 1.0% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
공고 • Jul 14Phyto Chem (India) Limited, Annual General Meeting, Aug 07, 2023Phyto Chem (India) Limited, Annual General Meeting, Aug 07, 2023, at 11:30 Indian Standard Time. Location: Survey No.628, Temple Street, Bonthapally - 502 313 Gummadidala Mandal, Sangareddy District, Telangana State Sangareddy India Agenda: To consider and approve the Audited Financial Statements of the Company as at 31 March 2023, along with the Reports of the Board of Directors and Auditors thereon; to consider and approve the appointment of a Director in place of Mr. Anjaneyulu Prathipati who retires by rotation and being eligible, offers himself for reappointment; and to consider other matters.
Valuation Update With 7 Day Price Move • Jun 12Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹38.44, the stock trades at a trailing P/E ratio of 74.4x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 33% over the past three years.
Reported Earnings • May 30Full year 2023 earnings released: EPS: ₹0.52 (vs ₹0.54 in FY 2022)Full year 2023 results: EPS: ₹0.52 (down from ₹0.54 in FY 2022). Revenue: ₹269.2m (up 16% from FY 2022). Net income: ₹2.22m (down 3.3% from FY 2022). Profit margin: 0.8% (down from 1.0% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings.
공고 • May 06Phyto Chem (India) Limited Announces Resignation of K.Ravindra Babu as an Independent Director, Effective from May 12, 2023Phyto Chem (India) Limited announced that Mr. K.Ravindra Babu has resigned from the position of the independent director of the company with effect from May 12, 2023.
Valuation Update With 7 Day Price Move • Mar 24Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₹27.14, the stock trades at a trailing P/E ratio of 78.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 51% over the past three years.
Reported Earnings • Feb 16Third quarter 2023 earnings released: ₹0.72 loss per share (vs ₹1.21 profit in 3Q 2022)Third quarter 2023 results: ₹0.72 loss per share (down from ₹1.21 profit in 3Q 2022). Revenue: ₹79.4m (up 4.1% from 3Q 2022). Net loss: ₹3.09m (down 160% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 36% per year, which means it is well ahead of earnings.
공고 • Feb 07Phyto Chem (India) Limited to Report Q3, 2023 Results on Feb 14, 2023Phyto Chem (India) Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 14, 2023
Valuation Update With 7 Day Price Move • Feb 03Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to ₹61.95, the stock trades at a trailing P/E ratio of 27.3x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 169% over the past three years.
Valuation Update With 7 Day Price Move • Jan 16Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹67.50, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 170% over the past three years.
Valuation Update With 7 Day Price Move • Jan 02Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹50.15, the stock trades at a trailing P/E ratio of 22.1x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 116% over the past three years.
Valuation Update With 7 Day Price Move • Dec 14Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹35.85, the stock trades at a trailing P/E ratio of 15.8x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 78% over the past three years.
Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₹34.40, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 47% over the past three years.
공고 • Oct 23Phyto Chem (India) Limited to Report Q2, 2023 Results on Oct 31, 2022Phyto Chem (India) Limited announced that they will report Q2, 2023 results at 2:30 PM, Indian Standard Time on Oct 31, 2022
Valuation Update With 7 Day Price Move • Sep 09Investor sentiment improved over the past weekAfter last week's 25% share price gain to ₹20.60, the stock trades at a trailing P/E ratio of 77.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 12% over the past three years.
공고 • Sep 06Phyto Chem (India) Limited, Annual General Meeting, Sep 28, 2022Phyto Chem (India) Limited, Annual General Meeting, Sep 28, 2022, at 11:45 Indian Standard Time. Location: Registered Office at Survey No. 628, Temple Street, Bonthapally Gummadidala Mandal Sangareddy India Agenda: To receive, consider and adopt the Audited Financial Statements of the Company as at 31% March 2022, along with the Reports of the Board of Directors and Auditors thereon; to consider directorate reelections; and to consider other matters.
Reported Earnings • Aug 10First quarter 2023 earnings released: ₹3.65 loss per share (vs ₹3.38 loss in 1Q 2022)First quarter 2023 results: ₹3.65 loss per share (down from ₹3.38 loss in 1Q 2022). Revenue: ₹14.1m (down 16% from 1Q 2022). Net loss: ₹15.7m (loss widened 8.0% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
Reported Earnings • Feb 15Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹1.21 (up from ₹0.94 in 3Q 2021). Revenue: ₹76.7m (up 31% from 3Q 2021). Net income: ₹5.18m (up 29% from 3Q 2021). Profit margin: 6.8% (down from 6.9% in 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
Reported Earnings • Jul 04Full year 2021 earnings released: EPS ₹1.15 (vs ₹1.04 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹452.9m (up 2.4% from FY 2020). Net income: ₹4.93m (up 11% from FY 2020). Profit margin: 1.1% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 23% per year, which means it is performing significantly worse than earnings.
Valuation Update With 7 Day Price Move • Jun 09Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹26.80, the stock trades at a trailing P/E ratio of 21.5x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 48% over the past three years.
Is New 90 Day High Low • Feb 22New 90-day low: ₹20.60The company is down 8.0% from its price of ₹22.35 on 24 November 2020. The Indian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.
Reported Earnings • Feb 13Third quarter 2021 earnings released: EPS ₹0.94 (vs ₹0.73 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹61.0m (down 65% from 3Q 2020). Net income: ₹4.03m (up 28% from 3Q 2020). Profit margin: 6.6% (up from 1.8% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 31% per year whereas the company’s share price has fallen by 26% per year.
공고 • Feb 05Phyto Chem (India) Limited to Report Q3, 2021 Results on Feb 12, 2021Phyto Chem (India) Limited announced that they will report Q3, 2021 results on Feb 12, 2021
Is New 90 Day High Low • Jan 04New 90-day high: ₹27.85The company is up 7.0% from its price of ₹26.15 on 06 October 2020. The Indian market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
Valuation Update With 7 Day Price Move • Dec 29Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹25.65, the stock is trading at a trailing P/E ratio of 24.6x, up from the previous P/E ratio of 20.9x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 66%.
공고 • Dec 06Phyto Chem (India) Limited, Annual General Meeting, Dec 28, 2020Phyto Chem (India) Limited, Annual General Meeting, Dec 28, 2020, at 11:45 Indian Standard Time. Location: Survey No.628, Tem ple Street Bonthapally - 502 313, Gummadidala Mandal Sangareddy Andhra Pradesh India Agenda: To consider and adopt the Audited Balance Sheet as at March 31, 2020, Profit and Loss Account and Cash Flow Statement for the year ended on that date along with the Reports of the Board of Directors and Auditors thereon; to consider the re-appointment of Mr. Anjaneyulu Prathipati as Director; to consider the re-appointment of Dr. G.S.R.Anjaneyulu as a Non-Executive Independent Director of the company; to consider the appointment of Mr. Ravindra Babu Kakarla as a Non-Executive Independent Director of the company; to consider the appointment of Mr. Yugandhar Sampath Kumar Sakhamuri as a Non-Executive Independent Director of the Company; to consider the appointment of Mrs. Vijitha Gorrepati as a Woman Non-Executive Independent Director of the Company; and to consider the Continuation of Directorship of Dr. Venkateswarlu Yadlapalli as a Non- Executive Non-Independent Director.
Reported Earnings • Nov 16Second quarter 2021 earnings released: EPS ₹2.91The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹177.1m (down 15% from 2Q 2020). Net income: ₹12.5m (down 19% from 2Q 2020). Profit margin: 7.1% (down from 7.4% in 2Q 2020). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings.
공고 • Nov 13Phyto Chem (India) Limited Announces Cessation of Independent DirectorsPhyto Chem (India) Limited announced that Mr. N. Sudhakar, Mr. T. A. Choudary and Mrs. S. Kavitha Rani as the cessation of independent directors effect from November 12, 2020.
Valuation Update With 7 Day Price Move • Oct 28Market bids up stock over the past weekAfter last week's 17% share price gain to ₹23.95, the stock is trading at a trailing P/E ratio of 13.8x, up from the previous P/E ratio of 11.8x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 62%.
Valuation Update With 7 Day Price Move • Oct 14Market pulls back on stock over the past weekAfter last week's 15% share price decline to ₹22.05, the stock is trading at a trailing P/E ratio of 12.7x, down from the previous P/E ratio of 15x. This compares to an average P/E of 15x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 65%.
Is New 90 Day High Low • Sep 18New 90-day low: ₹21.85The company is down 22% from its price of ₹28.00 on 19 June 2020. The Indian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period.
공고 • Sep 08Phyto Chem (India) Limited to Report Q1, 2021 Results on Sep 14, 2020Phyto Chem (India) Limited announced that they will report Q1, 2021 results on Sep 14, 2020
